Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | COLL | AMLX | ORKA | ||
| Company | Collegium Pharma | Amylyx Pharmaceuticals Inc | Oruka Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 47.92 | 14.29 | 31.42 | ||
| High | 49.04 | 14.76 | 31.74 | ||
| Low | 47.21 | 13.65 | 31.04 | ||
| Latest | 47.91 | 13.67 | 31.44 | ||
| Change | unch | -0.53 | +0.60 | ||
| % Change | unch | -3.73% | +1.96% | ||
| Volume | 687,198 | 1,036,728 | 387,876 | ||
| 20-Day Average Volume | 581,885 | 1,332,781 | 397,279 | ||
| Previous Close | 47.91 | 14.20 | 30.84 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 46.09 | 13.85 | 28.87 | ||
| 20-Day Raw Stochastic | 83.99% | 52.22% | 94.26% | ||
| 20-Day Relative Strength | 72.54 | 49.54 | 63.19 | ||
| Weighted Alpha | +76.14 | +203.63 | +142.46 | ||
| Today's Opinion | 100% Buy | 56% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 88% Buy | 100% Buy | ||
| Last Month's Opinion | 88% Buy | 56% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.24% since 12/01/25 | -4.00% since 12/01/25 | +13.64% since 12/01/25 | ||
| Low | 45.82 on 12/02/25 | 13.50 on 12/03/25 | 26.73 on 12/02/25 | ||
| High | 49.04 on 12/08/25 | 15.06 on 12/05/25 | 31.80 on 12/05/25 | ||
| 1-Month | |||||
| %Chg | +13.26% since 11/07/25 | +11.05% since 11/07/25 | +13.32% since 11/07/25 | ||
| Low | 41.98 on 11/10/25 | 11.79 on 11/10/25 | 25.62 on 11/14/25 | ||
| High | 49.04 on 12/08/25 | 15.39 on 11/24/25 | 31.80 on 12/05/25 | ||
| 3-Month | |||||
| %Chg | +26.91% since 09/08/25 | +30.94% since 09/08/25 | +99.02% since 09/08/25 | ||
| Low | 31.26 on 10/13/25 | 10.37 on 09/09/25 | 14.66 on 09/16/25 | ||
| High | 49.04 on 12/08/25 | 16.96 on 10/21/25 | 31.80 on 12/05/25 | ||
| 6-Month | |||||
| %Chg | +58.64% since 06/06/25 | +156.47% since 06/06/25 | +149.96% since 06/06/25 | ||
| Low | 29.08 on 06/13/25 | 4.80 on 06/23/25 | 10.77 on 06/23/25 | ||
| High | 49.04 on 12/08/25 | 16.96 on 10/21/25 | 31.80 on 12/05/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,514,483 | 1,559,444 | 1,492,934 | ||
| Shares Outstanding, K | 31,611 | 109,820 | 48,409 | ||
| Annual Sales | 631,450,000 | 87,370,000 | 0 | ||
| Annual Net Income | 69,190,000 | -301,740,000 | -83,720,000 | ||
| Last Quarter Sales | 209,360,000 | 0 | 0 | ||
| Last Quarter Net Income | 31,510,000 | -34,390,000 | -30,280,000 | ||
| 60-Month Beta | 0.61 | -0.34 | -0.41 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.25 on 11/06/25 | -0.37 on 11/06/25 | -0.55 on 11/12/25 | ||
| Latest Earnings Date | 11/06/25 | 11/06/25 | 11/12/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | 03/28/18 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 7.42 | 0.00 | 0.00 | ||